Fish Oil (Omega 3 ) in Sjogren's Syndrome

Status Completed

Clinical Trial Summary

Sjögren's syndrome (pSS) is an autoimmune disorder affecting mainly the exocrine glands.this lead to dryness of the main mucosal surface ,such as the mouth ,eye,skin nose,pharynx,larynx and vagina . The history of the disease is characterized by a slowly progression of sicca symptoms and fatigue; however, a subset of patients would experience extra glandular activity. Lipid mediators derived from polyunsaturated fatty acids, related to inflammation and immune response regulation. In this sense, the polyunsaturated fatty acids omega-3 (ω-3 FA) have been associated with several illnesses such as cancer, cardiovascular disease and autoimmune diseases and their balance at the cellular membranes can result in an anti-inflammatory .

Clinical Trial Description

this is a randomized double -blind placebo -controlled clinical trial .the participants will be randomize into two groups .Group 1 receive dietary omega-3 supplementation (omega-3 group) whereas Group 2(placebo group) receive a placebo . The two types are similar to each other in the form of soft gel ,both are given two times daily for two months with follow-up of patients whom they full fill the inclusion criteria. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05005806
Study type	Interventional
Source	Hawler Medical University
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	September 2, 2021
Completion date	February 7, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03248518` - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases	N/A
Completed	`NCT04968912` - A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)	Phase 2
Completed	`NCT03203382` - Corneal Nerve Structure in Sjogren's
Completed	`NCT00809003` - Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease	N/A
Completed	`NCT00023491` - Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells	N/A
Enrolling by invitation	`NCT03436576` - Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye	Phase 3
Terminated	`NCT04143841` - Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease	N/A
Completed	`NCT03611283` - Topical Management of Xerostomia With Dry Mouth Products	N/A
Recruiting	`NCT06104124` - A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity	Phase 3
Recruiting	`NCT05115487` - Evaluation of Hand Functions in Newly Diagnosed Primary Sjögren's Syndrome
Recruiting	`NCT06437652` - An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome
Recruiting	`NCT05383677` - Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome	Phase 2
Not yet recruiting	`NCT03938207` - Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed	`NCT04546542` - Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients
Recruiting	`NCT05085431` - A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome	Early Phase 1
Completed	`NCT00565526` - Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
Completed	`NCT01369589` - An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness	Phase 1/Phase 2
Completed	`NCT00001953` - The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers	N/A
Completed	`NCT00001731` - Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops	Phase 2